The role of adjuvant radiation and chemoradiation in single node-positive vulvar cancer

2014 ◽  
Vol 133 ◽  
pp. 36-37
Author(s):  
R.A. Laskey ◽  
M.S. Ross ◽  
J.F. Lin ◽  
P. Sukumvanich ◽  
T.C. Krivak ◽  
...  
2013 ◽  
Vol 87 (2) ◽  
pp. S128-S129 ◽  
Author(s):  
E. Xanthopoulos ◽  
N. Mitra ◽  
S. Grover ◽  
M.N. Corradetti ◽  
M. Mangaali ◽  
...  

2013 ◽  
Vol 31 (15_suppl) ◽  
pp. 5609-5609
Author(s):  
Eric Xanthopoulos ◽  
Surbhi Grover ◽  
Michael Nino Corradetti ◽  
Margaret Mangaali ◽  
Marina Heskel ◽  
...  

5609 Background: Adjuvant radiation (RT) has been demonstrated to improve overall survival (OS) in vulvar cancer patients with 2+ positive lymph nodes, but its role in patients with one positive lymph node is uncertain. We report on the largest and longest study of survival in patients with and without radiation following surgery in patients with vulvar cancer. Methods: Using the Surveillance, Epidemiology, and End Results (SEER) database, we identified node-positive women with squamous cell carcinoma of the vulva treated with and without external beam radiation following surgery. The Kaplan-Meier approach, log-rank tests and Cox modeling assessed OS. Results: All results are listed as women without vs with adjuvant radiation. From 1988 – 2008, 420 patients received surgery alone vs 753 women who received adjuvant radiation. Patient characteristics were well balanced across cohorts, including tumors ≤ or > than 2 cm (p = 0.31), grade (p = 0.41), marital status (p = 0.20), provider type (p = 0.49), and AJCC stage (p = 0.35). Both groups also had similar incidence of biopsy of any kind (p = 0.40), lymph node dissection (p = 0.77), median number of nodes excised (p = 0.12), and type of surgery (p = 0.49). Median age (75 vs 70 y, p <0.01) and race (94% vs 89% white, p = 0.01) were adjusted using Cox regression. Median survivor follow-up was 45 m (range 0 - 236 m). Adjuvant radiation was associated with survival across all node-positive patients (22 vs 29 m, p <0.01), as well as in the subset of women with just one positive lymph node (37 vs 70 m, p <0.01) or 2+ positive lymph nodes (14 vs 18 m, p <0.01). On multivariable Cox regression, adjuvant radiation (95% CI 0.85 - 0.96), diameter (CI 1.28 - 2.01), marital status (CI 0.65 - 0.93), the number of positive nodes (CI 1.06 - 1.11), and the ratio of positive-to-excised nodes (CI 1.61 - 2.98) were all associated with survival (p <0.01 for each). Conclusions: The largest cohort study of node-positive squamous cell carcinoma of the vulva suggests adjuvant radiation is associated with OS.Studies have reported that adjuvant radiation may provide a survival benefit in women with 2+ positive lymph nodes. Our findings suggest patients with one positive lymph node also may benefit from adjuvant radiation.


2018 ◽  
Vol 41 (9) ◽  
pp. 845-850 ◽  
Author(s):  
Eric P. Xanthopoulos ◽  
Surbhi Grover ◽  
Priya M. Puri ◽  
Michael N. Corradetti ◽  
Samuel P. Heilbroner ◽  
...  

2021 ◽  
Vol 39 (15_suppl) ◽  
pp. e16504-e16504
Author(s):  
Akshay G Reddy ◽  
Andrew D Sparks ◽  
Michael Joseph Whalen

e16504 Background: Given the rarity of bladder adenocarcinoma, there is a paucity of data examining the role of adjuvant chemotherapy (AC) in patients with regional lymph node positivity. This study aims to elucidate the oncologic and survival outcomes of patients with node-positive disease treated with or without AC. Methods: A retrospective cohort analysis of patients with node-positive primary bladder adenocarcinoma who had either received AC or did not receive AC after either radical (RC) or partial cystectomy (PC) was performed using the National Cancer Database from 2006 to 2016. Non-metastatic node-positive was defined as pT(any)N1-3 (pN+) disease. Demographic and clinicopathological variables were compared to adjust for confounding covariates in multivariable analysis to determine appropriate oncologic and surgical outcomes. Results: A total of 106 patients met inclusion criteria, of whom 38 received AC and 68 did not. Receipt of AC was significantly associated with improved survival relative to those who did not receive AC (overall survival: 29% vs 2.7%; adjusted hazards ratio = 0.43; p = 0.003) independent of extent of surgery. There was a trend toward higher receipt of adjuvant radiation along with AC, independent of surgical margin status. Receipt of AC additionally trended towards a significant association with decreased odds of 90-day mortality and 30-day unplanned readmission (Table). Conclusions: Based on the improved survival outcomes, positive nodal status may be a useful indicator of those who may benefit from AC, and potentially adjuvant radiation therapy, in bladder adenocarcinoma. Though compelling, larger studies will be required to make more conclusive statements regarding the most appropriate treatment course in these patients.[Table: see text]


2016 ◽  
Vol 141 (3) ◽  
pp. 434-439 ◽  
Author(s):  
Talha Shaikh ◽  
Thomas M. Churilla ◽  
Gina M. Mantia-Smaldone ◽  
Christina Chu ◽  
Stephen C. Rubin ◽  
...  

2016 ◽  
Vol 141 ◽  
pp. 43 ◽  
Author(s):  
T. Shaikh ◽  
T.M. Churilla ◽  
G.M. Mantia-Smaldone ◽  
C. Chu ◽  
S.C. Rubin ◽  
...  

2017 ◽  
Vol 146 (1) ◽  
pp. 87-93 ◽  
Author(s):  
Cameron W. Swanick ◽  
Patricia J. Eifel ◽  
Jinhai Huo ◽  
Larissa A. Meyer ◽  
Grace L. Smith

Sign in / Sign up

Export Citation Format

Share Document